|
|
糖肾康饮治疗糖尿病肾病的用药规律探讨
|
Abstract:
糖尿病肾病(DN)作为糖尿病微血管并发症之一，其发生和发展受到了医学研究者和临床医生的广泛关注。糖肾康饮，是中医治疗DN的经典药方，该方由黑龙江省名中医马建教授创制，针对DNIII期患者阴虚内热、耗气伤血以及由气虚引发瘀血的病理特征，以益气滋阴和化瘀活血为治疗原则所立，对DN及其相关症状有良好的治疗效果。本文通过深入探讨糖肾康饮的组方分析、药理研究及临床应用，为糖肾康饮在DN的治疗应用中提供更加全面的理论支持和科学依据。
As one of the microvascular complications of diabetes, the occurrence and development of diabetes nephropathy (DN) has received extensive attention from medical researchers and clinicians. Tangshenkang Decoction is a classic prescription for treating DN in traditional Chinese medicine. It was created by Professor Ma Jian, a renowned traditional Chinese medicine practitioner in Heilongjiang Province. It focuses on the pathological characteristics of Yin deficiency, internal heat, qi consumption, blood injury, and blood stasis caused by Qi deficiency in patients with DN III, and is based on the principles of supplementing qi, nourishing yin, and promoting blood stasis. It has a good therapeutic effect on DN and its related symptoms. This article provides more comprehensive theoretical support and scientific basis for the treatment and application of Tangshenkang Decoction in DN by deeply exploring the composition analysis, pharmacological research, and clinical application of Tangshenkang Decoction.
| [1] | Zhang, Y., Jin, D., Kang, X., Zhou, R., Sun, Y., Lian, F., et al. (2021) Signaling Pathways Involved in Diabetic Renal Fibrosis. Frontiers in Cell and Developmental Biology, 9, Article 696542. https://doi.org/10.3389/fcell.2021.696542 |
| [2] | Zheng, W., Guo, J. and Liu, Z. (2021) Effects of Metabolic Memory on Inflammation and Fibrosis Associated with Diabetic Kidney Disease: An Epigenetic Perspective. Clinical Epigenetics, 13, Article No. 87. https://doi.org/10.1186/s13148-021-01079-5 |
| [3] | Liu, J., Zhang, X. and Xu, G. (2022) Clinical Efficacy, Safety, and Cost of Nine Chinese Patent Medicines Combined with ACEI/ARB in the Treatment of Early Diabetic Kidney Disease: A Network Meta-Analysis. Frontiers in Pharmacology, 13, Article 939488. https://doi.org/10.3389/fphar.2022.939488 |
| [4] | Xuan, C., Xi, Y., Zhang, Y., Tao, C., Zhang, L. and Cao, W. (2021) Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats with Diabetic Nephropathy by Promoting Autophagy. Frontiers in Pharmacology, 12, Article 624404. https://doi.org/10.3389/fphar.2021.624404 |
| [5] | 郅扶旻, 薛影, 徐洪涛, 等. 马建教授治疗糖尿病肾病的经验总结[J]. 现代医学与健康研究电子杂志, 2021, 5(1): 140-142. |
| [6] | 薛影. 糖肾康饮治疗早期糖尿病肾病的临床疗效观察及对血清MMP-9的影响[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2022. https://doi.org/10.27127/d.cnki.ghlzu.2022.000520 |
| [7] | Li, G., Chung, K. and Poon, J. (2015) Evidence-Based Patient Classification for Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine, 2015, Article ID: 168343. https://doi.org/10.1155/2015/168343 |
| [8] | 李慧灵, 唐晨晨, 申雨萍, 杨悦玲. 糖尿病肾病发病机制与中西医治疗的研究进展[J]. 临床医学工程, 2023, 30(8): 1175-1176. |
| [9] | Long, C., Feng, H., Liu, Z., Li, Z., Liu, J., Jiang, Y., et al. (2023) Efficacy of Traditional Chinese Medicine Injection for Diabetic Kidney Disease: A Network Meta Analysis and Systematic Review. Frontiers in Pharmacology, 14, Article 1028257. https://doi.org/10.3389/fphar.2023.1028257 |
| [10] | Miao, H., Zhang, Y., Yu, X., Zou, L. and Zhao, Y. (2022) Membranous Nephropathy: Systems Biology-Based Novel Mechanism and Traditional Chinese Medicine Therapy. Frontiers in Pharmacology, 13, Article 969930. https://doi.org/10.3389/fphar.2022.969930 |
| [11] | 陈珂, 何泽云. 何泽云从肺论治慢性肾衰竭经验[J]. 中医药导报, 2023, 29(4): 206-208, 212. |
| [12] | 王晓光. 张琪教授治疗慢性肾功能衰竭经验介绍[J]. 中医杂志, 2010, 51(S2): 101-102. |
| [13] | 李清茹, 张琳琪. 张琳琪教授治疗慢性肾脏病常用药对浅析[J]. 中国中西医结合肾病杂志, 2022, 23(12): 1098-1099. |
| [14] | 王婧琳, 付新军, 李亚军. “茯苓”之文献考察: 名称、来源和功效[J]. 中药材, 2021, 44(1): 219-223. |
| [15] | 陈冉, 杨金月, 吴柳青, 等. 活血通络法治疗慢性肾功能衰竭的有效性和安全性的Meta分析[J]. 世界中西医结合杂志, 2023, 18(6): 1093-1102, 1108. |
| [16] | 高诗慧. 基于数据挖掘分析中药治疗气阴两虚型糖尿病肾脏疾病用药规律研究[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2022. |
| [17] | Chen, R., Liao, C., Guo, Q., Wu, L., Zhang, L. and Wang, X. (2018) Combined Systems Pharmacology and Fecal Metabonomics to Study the Biomarkers and Therapeutic Mechanism of Type 2 Diabetic Nephropathy Treated with astragalus and Leech. RSC Advances, 8, 27448-27463. https://doi.org/10.1039/c8ra04358b |
| [18] | Chen, J., Chen, Y., Shu, A., Lu, J., Du, Q., Yang, Y., et al. (2020) Radix Rehmanniae and Corni Fructus against Diabetic Nephropathy via AGE-RAGE Signaling Pathway. Journal of Diabetes Research, 2020, Article ID: 8358102. https://doi.org/10.1155/2020/8358102 |
| [19] | Zou, F., Mao, X., Wang, N., Liu, J. and Ou-Yang, J. (2009) Astragalus Polysaccharides Alleviates Glucose Toxicity and Restores Glucose Homeostasis in Diabetic States via Activation of AMPK. Acta Pharmacologica Sinica, 30, 1607-1615. https://doi.org/10.1038/aps.2009.168 |
| [20] | Guo, Q., Niu, W., Li, X., Guo, H., Zhang, N., Wang, X., et al. (2019) Study on Hypoglycemic Effect of the Drug Pair of Astragalus Radix and Dioscoreae Rhizoma in T2DM Rats by Network Pharmacology and Metabonomics. Molecules, 24, Article 4050. https://doi.org/10.3390/molecules24224050 |
| [21] | Lv, X., Dai, G., Lv, G., Chen, Y., Wu, Y., Shen, H., et al. (2016) Synergistic Interaction of Effective Parts in Rehmanniae Radix and Cornus Officinalis Ameliorates Renal Injury in C57BL/KsJ-db/db Diabetic Mice: Involvement of Suppression of AGEs/RAGE/SphK1 Signaling Pathway. Journal of Ethnopharmacology, 185, 110-119. https://doi.org/10.1016/j.jep.2016.03.017 |
| [22] | 李奕茜. 糖肾康饮对糖尿病肾病足细胞NLRP3炎性复合物的作用研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2018. |
| [23] | 王思凝. 糖肾康饮及拆方含药血清对高糖环境下肾小球系膜细胞的作用研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2017. |
| [24] | 王丹丹, 赵娜, 杨丽军, 等. 糖肾康浓缩丸对糖尿病肾病大鼠保护作用及机制研究[J]. 辽宁中医药大学学报, 2018, 20(9): 40-43. |
| [25] | 杨丽军. 糖肾康(浓缩)丸对糖尿病肾病大鼠的药效学及代谢组学研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2018. |
| [26] | 马建, 高悦, 刘春燕, 赵娜. 糖肾康水丸治疗Ⅲ期糖尿病肾病气阴两虚夹瘀证的临床观察[J]. 广州中医药大学学报, 2020, 37(3): 399-404. |
| [27] | 李超琳. 糖肾康水丸治疗早期糖尿病肾病的临床疗效观察及对血清IL-8的影响[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2019. |
| [28] | 佟美丽. 糖肾康水丸治疗早期糖尿病肾病的疗效观察及对血清TGF-β1的影响[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2019. |
